James Hunter

CNS pipeline · person

James Hunter, MBA

Director of Tonix Pharmaceuticals, appointed June 12, 2025. Brings over 40 years of commercial biopharmaceutical experience. Previously served as Executive Vice President of Commercial at Tonix (June 2023-December 2024), where he built the Tonix Medicines commercial subsidiary. Former CEO and Co-founder of Validus Pharmaceuticals. Holds a B.S. from Seton Hall University and an M.B.A. from Fairleigh Dickinson University.

  • 1 company

Courtesy Tonix Pharmaceuticals

Current roles

Past roles

Appears with

People sharing a company with James.

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.